Limits...
Evaluation of Dentifrice Containing Nano-hydroxyapatite for Dentinal Hypersensitivity: A Randomized Controlled Trial.

Gopinath NM, John J, Nagappan N, Prabhu S, Kumar ES - J Int Oral Health (2015)

Bottom Line: About 36 patients were selected, randomly divided into two groups and was evaluated clinically using three different stimuli, i.e., tactile, air blast, and cold water test.Statistical analysis was done using unpaired and paired t-tests.It was seen that patients treated in both groups showed significant reductions scores across all sensitivity measures at the end of 4 weeks.

View Article: PubMed Central - PubMed

Affiliation: Senior Lecturer, Department of Public Health Dentistry, Madha Dental College & Hospital, Chennai, Tamil Nadu, India.

ABSTRACT

Background: This randomized, double-blind, parallel arm study was carried out to evaluate and compare the effectiveness between nano-hydroxyapatite (HAP) and a benchmark dentifrice in reducing dentin hypersensitivity.

Materials and methods: About 36 patients were selected, randomly divided into two groups and was evaluated clinically using three different stimuli, i.e., tactile, air blast, and cold water test. The patient's responses to various stimuli were recorded using a visual analog scale at baseline and after 4 weeks.

Results: Statistical analysis was done using unpaired and paired t-tests. It was seen that patients treated in both groups showed significant reductions scores across all sensitivity measures at the end of 4 weeks.

Conclusion: The HAP containing toothpaste was effective in reducing dentin hypersensitivity with pre-existing benchmark toothpaste tested and hence can be advocated in the management of hypersensitivity.

No MeSH data available.


Related in: MedlinePlus

Distribution of subjects based on age and gender.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4588776&req=5

Figure 1: Distribution of subjects based on age and gender.

Mentions: Figure 1 shows the distribution of study subjects based on age and gender.


Evaluation of Dentifrice Containing Nano-hydroxyapatite for Dentinal Hypersensitivity: A Randomized Controlled Trial.

Gopinath NM, John J, Nagappan N, Prabhu S, Kumar ES - J Int Oral Health (2015)

Distribution of subjects based on age and gender.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4588776&req=5

Figure 1: Distribution of subjects based on age and gender.
Mentions: Figure 1 shows the distribution of study subjects based on age and gender.

Bottom Line: About 36 patients were selected, randomly divided into two groups and was evaluated clinically using three different stimuli, i.e., tactile, air blast, and cold water test.Statistical analysis was done using unpaired and paired t-tests.It was seen that patients treated in both groups showed significant reductions scores across all sensitivity measures at the end of 4 weeks.

View Article: PubMed Central - PubMed

Affiliation: Senior Lecturer, Department of Public Health Dentistry, Madha Dental College & Hospital, Chennai, Tamil Nadu, India.

ABSTRACT

Background: This randomized, double-blind, parallel arm study was carried out to evaluate and compare the effectiveness between nano-hydroxyapatite (HAP) and a benchmark dentifrice in reducing dentin hypersensitivity.

Materials and methods: About 36 patients were selected, randomly divided into two groups and was evaluated clinically using three different stimuli, i.e., tactile, air blast, and cold water test. The patient's responses to various stimuli were recorded using a visual analog scale at baseline and after 4 weeks.

Results: Statistical analysis was done using unpaired and paired t-tests. It was seen that patients treated in both groups showed significant reductions scores across all sensitivity measures at the end of 4 weeks.

Conclusion: The HAP containing toothpaste was effective in reducing dentin hypersensitivity with pre-existing benchmark toothpaste tested and hence can be advocated in the management of hypersensitivity.

No MeSH data available.


Related in: MedlinePlus